Industry Leaders Speculate On FTC Vs. Amgen/Horizon Fallout
Executive Summary
Pfizer chief clinical officer William Pao, Roche pharma CEO Teresa Graham and others weighed in on what FTC’s action could mean for pharma M&A at the Financial Times Pharma Summit.